Cardiovascular outcomes of glucagon-like peptide-1 receptor agonists in patients without obesity: a systematic review and meta-analysis of randomized controlled trials

By afschroeder • June 16, 2026

Waqas SA, Ibrahim M, Ahmed M, Waqas M, Aamir J, Fudim M, Musani MH, Fonarow GC, Greene SJ. Cardiovascular outcomes of glucagon-like peptide-1 receptor agonists in patients without obesity: a systematic review and meta-analysis of randomized controlled trials. J Diabetes Metab Disord. 2026 Jun 13;25(1):158. doi: 10.1007/s40200-026-01969-6. PMID: 42299230; PMCID: PMC13264643.

Tags: Cardiology/Epi, cardiovascular outcomes, GLP1 receptor agonists, heart failure, MACE, meta-analysis, Non-obese, Publications

Fatty Acid and Oxylipin Metabolism Differentiate Isolated Postcapillary From Combined Pre- and Postcapillary Pulmonary Hypertension

Alotaibi M, Tang A, Sun N, Gurholt I, Yuguchi E, Roberts K, Preston I, Warburton R, Yuan JX, Kim NH, Chan SY, Jain M, Cheng[...]

Artificial intelligence-enabled electrocardiography for detection of left ventricular diastolic dysfunction: a systematic review and meta-analysis

Edjimbi J, Shah N, Donisi L, Gajjar A, See C, Grimshaw AA, Diop HB, Ribeiro ALP, Marijon E, Clifford G, Gaye B. Artificial intelligence-enabled electrocardiography[...]

Heart failure among people with HIV: prescription of guideline-directed medical therapy

Cutshaw MK, Clare R, Chiswell K, Hofmann P, Pettit AC, Meissner E, Durstenfeld MS, Longenecker CT, Bloomfield GS, Okeke NL. Heart failure among people with[...]